Болезнь Бехчета (лекция)
https://doi.org/10.14412/1995-4484-2013-1202
Аннотация
Болезнь Бехчета (ББ) – системный васкулит неизвестной этиологии с мультиорганным поражением.
Об авторе
З. С. Алекберова
Федеральное государственное бюджетное учреждение Научно-исследовательский институт ревматологии» РАМН, Москва
д.м.н., профессор
д.м.н., профессор
Список литературы
1. <div><p>Yazici H., Fresco I., Stuebiger N. Behcet’s syndrome, relapsing polyhondritis and eye involvement in rheumatic disease. EULAR Compendium 2011;357—64.</p><p>Feingenbaum A. Description of Behcet’s syndrome in the Hippocratic third book of endemic disease. Brit Ophthalmology 1956;40:355-7.</p><p>Behcet H. Uber rezidivierende aphtose, durch in Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wschr 1937;105:1152-7.</p><p>Zouboulis Ch. Epidemiology of Adamantiades Behcet’s disease. Immunology of Behcet’s disease. Eds M. Zierhut, S. Ohno. Lisse, 2003;1-16.</p><p>Calamia K., "Wilson F., Ycen M. et al. Epidemiology and clinical characteristics of Behcet's disease in the US: population based study. Arthr Rheum 2009;61(5):600-4.</p><p>Yazici Y., Yurdakul S., Yazici H. Behcet’s syndrome: an update. Int J Adv Rheumatol 2009;7(1):19—21.</p><p>Yazici H., Tuzun Y., Pazarli H. et al. Influence of age on onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Ann Rheum Dis 1984;43(78):3—9.</p><p>Hamuryudan V., Hatemi G., Sut N. et al. Freqent oral ulceration during early disease may predict a severe disease course in males with Behcet’s syndrome. Clin Exp Rheumatology 2012;30(3; Suppl 72):32-4.</p><p>Ohno S., Ohguchi M., Hirose S. et al. Close association of HLA BW51 with Behcet’s disease. Arch Ophtalmol 1982;100:1455-8.</p><p>Muller C., Cunaydin I., Stubiger N. et al. Association of HLA B51 suballeles with Behcet’s Disease in patients of German and Turkish Origin Immunology of Behcet’s disease. Eds M. Zierhut, S. Ohno. Lisse, 2003;121—6.</p><p>Алекберова З.С., Крылов М.Ю., Гусева И.А., Насонов Е.Л. HLAA26(10) антиген не ассоциирован с болезнью Бехчета в смешанной мультиэтнической выборке больных. Мед генет 2012;6:35-8.</p><p>Meguro A., Inoko H., Ota M. et al. Genetics of Behcet’s disease inside and outside the MHC. Ann Rheum Dis 2010;69(4):747-54.</p><p>Gul A., Jnanc M., Ocul L. et al. Familial aggregation on Behcet’s disease in Turkey. Ann Rheum Dis 2000;59:622-5.</p><p>Kaya T. Genetics of Behcet’s Disease. Pathol Res Intern 2012;912589;6p.</p><p>International Study group Behcet’s disease: Criteria for diagnosis of Behcet’s. Lancet 1990;335:1078-80.</p><p>Mizushima Y. Revized diagnostic criteria for Behcet’s disease in 1987. Ryumachi 1988;28(1):66-70.</p><p>Wechler B., Sable-Fourttaason R., Bodaghi B. et al. Infliximab in refractory uveitis due to Behcet’s disease. Clin Exper Rheum 2004;22(Suppl 34):14-6.</p><p>Tugal-Tutkun J., Onal S., Yaycioglu R. et al. Uveitis in Behcet’s disease: analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.</p><p>Ideguchi H., Suda A., Takeno M. et al. Behcet’s disease: evolution of clinical manifestations. Medicine (Baltimore) 2011;90:125-32.</p><p>Duzgun N., Ates A., Aydintug O.T. et al. Characteristics of vascular involvement in Behcet’s disease. Scand J Rheumatol 2006;35:65-8.</p><p>Koc Y., Gullu I., Akpek G. et al. Vascular involvement in Behcet’s disease. J Rheumatol 1992;19:402-10.</p><p>Saadoun D., Wechler B., Desseaux K. et al. Mortality in Behcet’s disease. Arthr Rheum 2010;62:2806-12.</p><p>Seyachi E., Yurdakul S. Behcet’s disease and tromboses: Mediterranean J Hematol Infect Dis 2011;3:26.</p><p>Lee S.K., Kim B.K., Kim T.I., Kim W.H. Differential diagnosis of intestinal Behcet’s disease and Crohn’s disease by colonoscopic. Endoscopy 2009;41(1):9—16.</p><p>Siva A., Saip S. The spectrum of nervous system involvement in Behcet’s syndrome and it’s differential diagnosis. J Neurol 2009;256:513-29.</p><p>Hatemi G., Silman A., Bang D. et al. EULAR recommendations for the management of Behcet’s disease. Ann Rheum Dis 2008;12:1656-62.</p><p>Ohno S. Anti-TNF therapy for intractable uveoretinitis in Behcet’s disease. 15th International Conference on Behcet’s Disease. 13th—15th July 2012 Yokohama, Japan. Abstr p. 37</p><p>Davatchi F., Shams H., Rezaipoor M. et al. Rituximab in intractable ocular lesions of Behcet’s disease: randomized singleblind control study (pilot-study). Int J Rheum Dis 2010;13:246-52.</p><p>Cantini F., Salvarani C., Niccoli L. et al. Treatment of thrombophlebitis of Behcet’s disease with low dose cyclosporine A. Clin Exp Rheumatol 1999;17:391-2.</p><p>Uzun O., Akpolat T., Erkam L. Pulmonary vasculitis in Behcet’s disease: a cummulative analysis. Chest 2005;127:2243-53.</p><p>Yazici H., Esen F. Mortality in Behcet’s syndrome. Clin Exp Rheumat 2008;26(Suppl 51):138-40.</p></div><br />
Рецензия
Для цитирования:
Алекберова З.С. Болезнь Бехчета (лекция). Научно-практическая ревматология. 2013;51(1):52-58. https://doi.org/10.14412/1995-4484-2013-1202
For citation:
Alekberova Z.S. Behcet's disease (a lecture). Rheumatology Science and Practice. 2013;51(1):52-58. (In Russ.) https://doi.org/10.14412/1995-4484-2013-1202
Просмотров:
1270
Послать статью по эл. почте 